Alopecia Market to Register Stunning Growth During the Forecast Period – DelveInsight | Key Companies – Pfizer, Merck, Histogen, Samumed, Follicum AB, Cassiopea, Legacy Healthcare, Concert Pharma

August 02 21:30 2022
Alopecia Market to Register Stunning Growth During the Forecast Period - DelveInsight | Key Companies - Pfizer, Merck, Histogen, Samumed, Follicum AB, Cassiopea, Legacy Healthcare, Concert Pharma
Delveinsight Business Research LLP
The Alopecia market size is expected to increase in the coming years owing to the rise in the prevalence of alopecia and the expected launch of emerging therapies. The ongoing Research and Development (R&D) activities and the active participation of the global pharma and biotech giants in the therapeutic segment will also stimulate market growth.

DelveInsight’s “Alopecia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Alopecia Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Alopecia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Alopecia Market

Alopecia: An Overview

Hair loss, also known as alopecia or baldness, refers to hair loss from part of the head or body. Typically, at least the head is involved, and the severity of hair loss can vary from a small area to the entire body.

About one-third of women experience hair loss at some time in their lives; among postmenopausal women, as many as two-thirds suffer hair thinning or bald spots. Hair loss in women often has a greater impact than hair loss does on men, because it is less socially acceptable for them. Alopecia can severely affect a woman’s emotional well-being and quality of life.

Alopecia Market Key Facts

  • According to the National Alopecia Areata Foundation, alopecia areata affects as many as 6.8 million people in the US with a lifetime risk of 2.1%. People of all ages, both sexes and all ethnic groups can develop alopecia areata.

  • As per the National Organization of Rare Diseases, alopecia areata is most common among children, and approximately 2.5 million people are suffering from alopecia areata in the United States.

  • According to the National Institute of Health, androgenetic alopecia affects an estimated 50 million men and 30 million women in the United States. Androgenetic alopecia can start as early as a person’s teens and the risk increases with age; more than 50% of men over age 50 have some degree of hair loss. In women, hair loss is most likely after menopause.

  • As per the article by Whiting et al. titled, “Cicatricial alopecia: clinicopathological findings and treatment,” the prevalence of cicatricial alopecia in the US is 7%.

Alopecia Market 

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Alopecia market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Alopecia market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Alopecia Epidemiology 

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Alopecia Epidemiology Segmentation – 

  • Total Prevalent Cases of Alopecia

  • Type-specific Prevalent Cases of Alopecia

  • Gender-specific Prevalent Cases of Alopecia

  • Diagnosed and Treatable Cases of Alopecia

  • Age-specific Prevalent Cases of Alopecia

Alopecia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alopecia market or expected to get launched during the study period. The analysis covers Alopecia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Alopecia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Alopecia Therapeutics Analysis

The treatment of alopecia depends on the subtype of the disease. There are various types of alopecia such as alopecia areata (AA), androgenetic alopecia (AGA), scarring alopecias (cicatricial alopecias), telogen and anagen effluvium, and traction alopecia. The most common type of alopecia is AA and AGA.

Companies across the globe are diligently working toward the development of novel treatment therapies for Alopecia with a considerable amount of success over the years.

Some of the key companies in the Alopecia Market include:

  • Pfizer

  • Merck

  • Histogen

  • Samumed

  • Follicum AB

  • Cassiopea

  • Legacy Healthcare

  • Johnson & Johnson

  • Concert Pharmaceuticals

And many others.

Alopecia Therapies covered in the report include:

  • PF-06651600

  • LH-8

  • SM04554

  • Follicum AB

  • HST 001

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Alopecia Competitive Intelligence Analysis

4. Alopecia Market Overview at a Glance

5. Alopecia Disease Background and Overview

6. Alopecia Patient Journey

7. Alopecia Epidemiology and Patient Population

8. Alopecia Treatment Algorithm, Current Treatment, and Medical Practices

9. Alopecia Unmet Needs

10. Key Endpoints of Alopecia Treatment

11. Alopecia Marketed Products

12. Alopecia Emerging Therapies

13. Alopecia Seven Major Market Analysis

14. Attribute Analysis

15. Alopecia Market Outlook (7 major markets)

16. Alopecia Access and Reimbursement Overview

17. KOL Views on the Alopecia Market.

18. Alopecia Market Drivers

19. Alopecia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Urinary Tract Infection Devices Market
“Urinary Tract Infection Devices Market” research report provides comprehensive insights into the historic and forecasted market size, share, trends, and growth estimation for Urinary Tract Infection Devices. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices, and key companies working in the global Urinary Tract Infection Devices market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States